The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds Salix
Pharmaceuticals, Inc. (“Salix”) (NasdaqGS:SLXP) investors of the January
6, 2015 deadline to move for appointment as lead plaintiff in the securities
class litigation brought on behalf of investors who purchased or
otherwise acquired Salix securities between November 7, 2013 and
November 6, 2014, inclusive (the “Class Period”).
If you purchased or otherwise acquired Salix securities during the Class
Period, you may move the Court for appointment as lead plaintiff by no
later than January 6, 2015.
for Lieff Cabraser Reminds Salix Pharmaceuticals, Inc. Investors of January 6, 2015 Lead Plaintiff Deadline in Class Litigation - SLXP investment picks